InVivo Therapeutics Holdings Corp (OTCQB:NVIV)

2.93
Delayed Data
As of Feb 27
 +0.32 / +12.26%
Today’s Change
0.47
Today|||52-Week Range
2.98
+121.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization44.9K144.7K366.9K740.7K
 
 
 
 
 
 
Operating ExpensesGross Income-44.9K-144.7K-366.9K-740.7K
 
 
 
 
 
General Expenses3.4M8.5M12.4M18.3M
 
 
 
 
 
Research And Development1.7M4.1M6.4M10.5M
 
 
 
 
 
Total Operating Expenses3.4M8.7M12.8M19.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-8.7M-12.8M-19.0M
 
 
 
 
 
Extraordinary Credit0.000.0017.5M--
 
 
Extraordinary Charge-5.1M-26.1M0.00-19.6M
 
 
 
 
Interest Expense On Debt564.4K16.7K71.7K129.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.1M-34.7M4.7M-38.8M
 
 
 
 
 
Net Income-9.1M-34.7M4.7M-38.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.4M51.9M63.2M74.0M
 
 
 
 
 
Shares To Calculate EPS Diluted33.4M51.9M71.9M74.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.67$0.06-$0.52
 
 
 
 
 
EPS Diluted-$0.27-$0.67$0.06-$0.52
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account